<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01218854</url>
  </required_header>
  <id_info>
    <org_study_id>100217</org_study_id>
    <secondary_id>10-CC-0217</secondary_id>
    <nct_id>NCT01218854</nct_id>
  </id_info>
  <brief_title>A Comparison of Methods for Assisting Needle Angle Selection During Image-guided Tissue Biopsy</brief_title>
  <official_title>A Comparison of Methods for Assisting Needle Angle Selection During Image-Guided Tissue Biopsy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Institutes of Health Clinical Center (CC)</agency>
      <agency_class>NIH</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Institutes of Health Clinical Center (CC)</source>
  <brief_summary>
    <textblock>
      Background:

      - Currently, standard procedures for biopsies that are guided by computed tomography (CT)
      imaging involve CT scans and a computer program to plan and illustrate where the physician
      will place the needle to obtain the required cells or tissue. Inserting the biopsy needle at
      the planned angle is not an easy task, because the appropriate angle of insertion must be
      estimated based on prior experience. Researchers are studying experimental techniques that
      might provide better guidance about the right angle to insert the biopsy needle and thereby
      improve the collection of the appropriate biopsy cells or tissue.

      Objectives:

      - To evaluate the effectiveness of two biopsy needle guidance methods in CT-guided tissue
      biopsy.

      Eligibility:

      - Individuals at least 18 years of age who are scheduled to have CT-guided tissue biopsy.

      Design:

        -  Participants will have a tissue biopsy guided by CT scans and either a laser system or a
           plastic block to illustrate the appropriate angle of insertion. The skin will be numbed
           with anesthetic to minimize discomfort during the procedure.

        -  Before inserting the biopsy needle, the study physician will hold the needle in place so
           that a Food and Drug Administration-approved medical GPS (electromagnetic tracking)
           system can measure the needle angle as it enters the tissue.

        -  After the needle angle data has been collected, researchers will proceed with the actual
           biopsy procedure as it would normally occur, using standard methods.

        -  No additional treatment will be provided as part of this protocol.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Background:

        -  Currently, standard/conventional CT-guided biopsies proceed as follows the physician:

             1. obtains a pre-procedural CT scan,

             2. plans the needle s angle based on this CT scan,

             3. selects the angle at which the needle should be inserted based on the
                pre-procedural CT scan,

             4. inserts the needle while aiming to replicate that planned needle angle by using
                only their visual-spatial abilities, and

             5. re-images the patient to confirm needle location followed by needle

                repositioning, if needed.

        -  Improving upon these standard methods of needle placement could have

      widespread benefits (e.g. improved diagnostic tissue sampling, decreased

      needle repositionings, etc.) We will be studying three needle angle selection systems. The
      laser-assisted needle angle selection system or LNASS, is a custom fabricated device that
      uses a Class II pointer similar to ones used for pointing at slides during lectures.

      Objectives:

        -  To compare the angle difference between L-NASS (Method A) and the standard method
           (clinician intuition/conventional method)

        -  To compare the angle difference between B-NASS (Method B) and the standard method
           (clinician intuition)

        -  To compare the angle difference between the mobile device-NASS or MD-NASS (C) and the
           standard method (clinician intuition/conventional method)

      Eligibility:

        -  Ages Eligible for Study: 18 Years and older

        -  Genders Eligible for Study: Both

        -  Inclusion:

             -  Must be undergoing a scheduled CT-guided biopsy.

             -  Must have ability to follow breathing instructions like holding breath (if
                procedure is to be performed without general anesthesia).

        -  Exclusion:

        -  No serious concurrent medical illness that would preclude the patient from making a
           rational informed decision on participation.

        -  Any known allergy to plastics or polymers (since the Ultem polymer could theoretically
           induce a rash in these patients, even though it is hypoallergenic).

        -  Pacemakers or automatic implantable cardiac defibrillators.

        -  Gross body weight above the CT table limit (450 pounds).

      Design:

        -  Primary outcome measure for the first arm is:

           --The difference between planned and achieved needle angle of a laser-assisted needle
           angle selection system with the standard method (clinician s intuition or conventional
           method) of CT-guided biopsy.

        -  Primary outcome measure for the second arm is:

           --The difference between planned and achieved needle angle of a block with pre-drilled
           needle angles with the standard method (clinician s intuition or conventional method) of
           CT-guided biopsy

        -  Primary outcome for the third arm is:

           --The difference between planned and achieved needle angle of a mobile device-assisted
           needle angle selection system with the standard method (clinician's intuition or
           conventional method) of CT-guided biopsy.

        -  The tool for measuring the needle angles will be an FDA-approved electromagnetic
           tracking system, which tracks needle movement and position.

        -  These comparisons will be done as a bystander study.

        -  Needle guidance system will only be used initially to select the angle during a
           superficial, shallow needle insertion at the skin surface (less than 1 cm deep).

        -  At no time will the needle enter tissue that it wouldn t have otherwise entered as none
           of the system will be used to perform the biopsies at this time.

        -  The key portions of the procedure will not be altered in any substantive way.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>September 20, 2010</start_date>
  <completion_date type="Actual">November 16, 2016</completion_date>
  <primary_completion_date type="Actual">November 16, 2016</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The difference between planned and achieved needle angle of a laser-assisted needle angle selection system with the standard method (clinicians intuition) of CT guided biopsy</measure>
    <time_frame>Completion of study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The difference between planned and achieved needle angle of a block with pre-drilled needle angles with the standard method (clinician's intuition)</measure>
    <time_frame>End of study</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>The difference between planned and achieved needle angle of an iPhone</measure>
    <time_frame>End of study</time_frame>
  </primary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Actual">17</enrollment>
  <condition>Lung Neoplasms</condition>
  <condition>Liver Neoplasms</condition>
  <condition>Kidney Neoplasms</condition>
  <condition>Cancer</condition>
  <arm_group>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Clinician intuition method</description>
  </arm_group>
  <arm_group>
    <arm_group_label>L-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Laser assisted needle angle selection system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>B-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Block assisted needle angle selection system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>MD-NASS</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>mobile-device assisted needle angle selection system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Needle angle measurement</intervention_name>
    <description>The tool for measuring the needle angles will be an FDA-approved EM tracking system. At no time will the needle enter tissue that it wouldn t have otherwise entered as neither system will be used to perform the biopsies at this time.</description>
    <arm_group_label>Standard</arm_group_label>
    <arm_group_label>L-NASS</arm_group_label>
    <arm_group_label>B-NASS</arm_group_label>
    <arm_group_label>MD-NASS</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        -  INCLUSION CRITERIA:

        Patients must fulfill all of the following criteria to be eligible for study admission:

          -  All patients must be undergoing a CT-guided biopsy.

          -  Age greater than 18 years.

          -  No serious concurrent medical illness that would preclude the patient from making a
             rational informed decision on participation.

          -  The ability to understand and willingness to sign a written informed consent form, and
             to comply with the protocol. If in question, an ethics consult will be obtained.

          -  Ability to follow breathing instructions like holding breath (if procedure is to be
             performed without general anesthesia).

          -  Patients must be actively enrolled on an NIH protocol and be scheduled for a CT-guided
             biopsy.

        EXCLUSION CRITERIA:

          -  Patients with an altered mental status that precludes understanding or consenting for
             the biopsy procedure will be excluded from this study.

          -  Patients unlikely to be able to hold reasonably still on a procedure table for the
             length of the procedure.

          -  Patients with any known allergy to plastics or polymers (since the Ultem -polymer
             could theoretically induce a rash in these patients, even though it is
             hypoallergenic).

          -  Inability to follow breathing instructions, if without general anesthesia.

          -  Patients with pacemakers or automatic implantable cardiac defibrillators.

          -  Gross body weight above the CT table limit (450 pounds).
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>100 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Bradford J Wood, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Institutes of Health Clinical Center (CC)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Institutes of Health Clinical Center, 9000 Rockville Pike</name>
      <address>
        <city>Bethesda</city>
        <state>Maryland</state>
        <zip>20892</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>https://clinicalstudies.info.nih.gov/cgi/detail.cgi?B_2010-CC-0217.html</url>
    <description>NIH Clinical Center Detailed Web Page</description>
  </link>
  <reference>
    <citation>Miaux Y, Guermazi A, Gossot D, Bourrier P, Angoulvant D, Khairoune A, Turki C, Bouch√© E. Laser guidance system for CT-guided procedures. Radiology. 1995 Jan;194(1):282-4.</citation>
    <PMID>7997570</PMID>
  </reference>
  <reference>
    <citation>Pereles FS, Baker M, Baldwin R, Krupinski E, Unger EC. Accuracy of CT biopsy: laser guidance versus conventional freehand techniques. Acad Radiol. 1998 Nov;5(11):766-70.</citation>
    <PMID>9809074</PMID>
  </reference>
  <reference>
    <citation>Jacobi V, Thalhammer A, Kirchner J. Value of a laser guidance system for CT interventions: a phantom study. Eur Radiol. 1999;9(1):137-40.</citation>
    <PMID>9933397</PMID>
  </reference>
  <verification_date>November 9, 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 8, 2010</study_first_submitted>
  <study_first_submitted_qc>October 8, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 11, 2010</study_first_posted>
  <last_update_submitted>May 9, 2018</last_update_submitted>
  <last_update_submitted_qc>May 9, 2018</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 10, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Biopsy</keyword>
  <keyword>Surgical Navigation</keyword>
  <keyword>Image-guided Therapy</keyword>
  <keyword>CT- Guided Biopsy</keyword>
  <keyword>Cancer</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neoplasms</mesh_term>
    <mesh_term>Lung Neoplasms</mesh_term>
    <mesh_term>Liver Neoplasms</mesh_term>
    <mesh_term>Kidney Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

